PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Wall St gains on earnings; Internet stocks lead

Tue, 22nd Apr 2014 14:21

* S&P 500, Nasdaq on track for six-day advance

* Netflix up after results, Facebook gains on update

* Allergan soars as Ackman and Valeant bid for company

* Indexes up: Dow 0.4 pct, S&P 0.4 pct, Nasdaq 0.7 pct (Updates to open, adds housing data)

By Ryan Vlastelica

NEW YORK, April 22 (Reuters) - U.S. stocks rose on Tuesday,with both the S&P 500 and Nasdaq on track for a sixth straightday of gains as a number of bellwether companies reported strongresults.

Netflix Inc surged 7.1 percent to $373.13 a dayafter results showed strong subscriber growth, a sign thetrading favorite still had room to grow despite recent concernsover its valuation.

Also helping lift the Internet space was Facebook Inc, which rose 2.3 percent to $62.64 after Credit Suisseupgraded the social networking company to "outperform."

Dow components Travelers Cos Inc and UnitedTechnologies Corp both reported first-quarter earningsthat beat expectations, and United Tech raised the low end ofits full-year profit outlook. Shares of Travelers rose 0.7percent to $87.04 while United Tech was up 1 percent at $119.49.

On the downside, McDonald's Corp reported earningsthat fell alongside a drop in U.S. same-store sales. Shares ofthe Dow component fell 0.2 percent to $99.45.

Better-than-expected earnings have lifted equities recently,though companies have largely been exceeding reduced forecasts.Profits are seen rising 1.1 percent this quarter, down from the6.5 percent growth rate estimated at the start of the year.

"The season has been better than many have feared, which ishelping investors feel comfortable with the pace of economicgrowth, now just in the first quarter but going forward," saidJoseph Tanious, global market strategist at J.P. Morgan AssetManagement in New York.

With 20 percent of the S&P having reported, 63 percent havetopped earnings expectations, according to Thomson Reuters data,even with the long-term average. On revenue, 51 percent haveexceeded forecasts, below the 61 percent long-term average.

The Dow Jones industrial average was up 57.83 points,or 0.35 percent, at 16,507.08. The Standard & Poor's 500 Index was up 7.23 points, or 0.39 percent, at 1,879.12. TheNasdaq Composite Index was up 29.53 points, or 0.72percent, at 4,151.08.

Both the S&P and Nasdaq are on track for a sixth straightday of gains. The S&P has gained 3.5 percent over that periodwhile the Nasdaq is up 3.8 percent.

In company news, Allergan Inc jumped 17.5 percent to$166.75 a day after activist investor William Ackman teamed upwith Canadian drugmaker Valeant Pharmaceuticals InternationalInc to bid for the company.

General Motors Co filed a motion in a U.S. bankruptcycourt to enforce a bar on lawsuits related to ignition defectsin cars sold before its 2009 bankruptcy as it fights a classaction lawsuit that seeks to set aside the restriction. Sharesof the automaker rose 0.7 percent to $34.21.

In the latest economic data, existing home sales fell totheir lowest level in more than 1-1/2 years in March, though thedecline was narrower than expected. (Editing by Nick Zieminski)

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.